21 0

Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-alpha-induced hepatic lipogenesis through AMP-activated protein kinase activation

Title
Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-alpha-induced hepatic lipogenesis through AMP-activated protein kinase activation
Author
김영미
Keywords
ELEMENT-BINDING PROTEIN-1C; MYRISTICA-FRAGRANS NUTMEG; ENDOTHELIAL-CELLS ROLE; FATTY LIVER; METABOLIC SYNDROME; MOUSE-LIVER; EXPRESSION; PATHWAY; STEATOSIS; SREBP-1C
Issue Date
2015-11
Publisher
GOVI-VERLAG PHARMAZEUTISCHER VERLAG GMBH
Citation
PHARMAZIE, v. 70, No. 11, Page. 733-739
Abstract
Nonalcoholic fatty liver disease is recognized as the most commonly occurring chronic liver disease. Liver X receptor alpha (LXR alpha) and sterol regulatory element-binding protein (SREBP)-1c play a central role in de novo fatty acid synthesis. This study investigated pharmacological effects of nectandrin B, a lignan isolated from nutmeg extract, on hepatic lipogenesis stimulated by LXR alpha -SREBP-1c-mediated pathway and the possible molecular basis. The reporter gene assay revealed that nectandrin B completely represses LXR alpha activity enhanced by a synthetic LXR alpha ligand (T0901317) in HepG2 cells. The inhibitory effect was further supported by the suppression of mRNA expression of LXR alpha target genes, SREBP-1c and LXR alpha itself. Nectandrin B also inhibited the increase in SREBP-1c expression promoted by insulin plus high glucose, major contributors to hepatic lipid accumulation. LXR alpha -SREBP-1c-mediated induction of acetylCoA carboxylase 1 and fatty acid synthase, major genes for de novo lipogenesis, was suppressed by nectandrin B. Moreover, Oil Red O staining showed that nectandrin B notably attenuates LXR alpha-induced lipid accumulation. AMP-activated protein kinase (AMPK) inhibits the activities of LXR alpha and SREBP-1c. Nectandrin B strongly activated AMPK signaling in HepG2 cells. Taken together, the suppressive effects of nectandrin B on lipogenic gene expression and lipid accumulation in hepatocytes may be due to its inhibitory effect on the LXR alpha-SREBP-1c pathway presumably via AMPK activation. These results suggest the potential of nectandrin B as a therapeutic candidate for fatty liver disease.
URI
https://www.ingentaconnect.com/contentone/govi/pharmaz/2015/00000070/00000011/art00007http://repository.hanyang.ac.kr/handle/20.500.11754/101939
ISSN
0031-7144
DOI
10.1691/ph.2015.5661
Appears in Collections:
COLLEGE OF PHARMACY[E](약학대학) > PHARMACY(약학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE